Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Barrett Esophagus 2Adenocarcinoma Of Esophagus 2Stomach Neoplasms 1Lymphoma, Mantle-Cell 1Gastrointestinal Neoplasms 1Gastroesophageal Reflux 1Colorectal Neoplasms 1Cholangiocarcinoma 1Carcinoma, Hepatocellular 1Adenomatous Polyposis Coli 1

Interventions

Oxaliplatin 25Fluorouracil 20Capecitabine 17Nivolumab 16pembrolizumab 15Leucovorin 13Trastuzumab 9fludarabine 8S 1 (combination) 8Paclitaxel 8Drug Therapy 8Docetaxel 8Cyclophosphamide 8Specimen Handling 7trastuzumab deruxtecan 6Cisplatin 6Magnetic Resonance Spectroscopy 5Biopsy 5Bevacizumab 5zolbetuximab 4Irinotecan 4zimberelimab 3sintilimab 3fludarabine phosphate 3atezolizumab 3aldesleukin 3XELOX 3Surgical Procedures, Operative 3Ramucirumab 3Radiotherapy 3

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Stomach Neoplasms × Endoscopy, Digestive System × 90 days × Clear all
NCT06408220 2026-03-13

Risk Assessment Evaluation for Identifying Participants at High Risk for Stomach Cancer

City of Hope Medical Center

Phase NA Recruiting
240 enrolled
Gastrointestinal

Stomach Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡